cro.directory
← Compare landing

Genelife Clinical Research Pvt. Ltd. vs Premier Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryGenelife Clinical Research Pvt. Ltd.Premier Research
SummaryCDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs.Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Device & Combination Product Services
Modalities
  • Small Molecule
  • Biologics (Other)
  • Peptide
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
Indications
  • Oncology
  • Neurology
  • Cardiovascular
  • Dermatology
  • Oncology
  • Immunology
  • Neurology
  • Infectious Disease
  • Rare Disease
  • Dermatology
  • Women's Health
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Real-World Evidence (RWE) / Registries
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical (General)
  • Real-World Evidence (RWE) / Registries
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Mumbai, India (Headquarters), Mumbai, India
  • Carson, California, Carson, California, USA
  • Cambridge, UK, Cambridge, United Kingdom
  • Hamburg, Germany, Hamburg, Germany
  • Headquarters, Morrisville, NC, United States
  • Southbank, Southbank, VIC, Australia
  • Sofia, Sofia, Bulgaria
  • Toronto, Mississauga, ON, Canada
  • Prague, Praha, Czech Republic
  • Paris, Paris, France
  • Darmstadt, Darmstadt, Germany
  • Budapest, Budapest, Hungary
  • Bengaluru, Bengaluru, India
  • Auckland, Auckland, New Zealand
  • Warsaw, Warszawa, Poland
  • Bucharest, Bucharest, Romania
  • Bratislava, Bratislava, Slovakia
  • Seoul, Seoul, South Korea
  • Madrid, Madrid, Spain
  • Taipei, Taipei, Taiwan
  • Kyiv, Kyiv, Ukraine
  • Wokingham, Wokingham, Berkshire, United Kingdom
Certifications
  • CDSCO · Identifier: CRO/MH/2026/000159
Data not yet provided.

Find similar companies

Genelife Clinical Research Pvt. Ltd. alternatives · Premier Research alternatives

Markdown mirror: /compare/genelifecr/premier-research.md